Compare · DNA vs TWST
DNA vs TWST
Side-by-side comparison of Ginkgo Bioworks Holdings Inc. (DNA) and Twist Bioscience Corporation (TWST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DNA and TWST operate in Biotechnology: Biological Products (No Diagnostic Substances) (Health Care), so they compete in similar markets.
- TWST is the larger of the two at $7.40B, about 11.9x DNA ($623.0M).
- TWST has been more active in the news (18 items in the past 4 weeks vs 8 for DNA).
- Both have 18 recent analyst ratings on file.
- Company
- Ginkgo Bioworks Holdings Inc.
- Twist Bioscience Corporation
- Price
- -
- -
- Market cap
- $623.0M
- $7.40B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Biotechnology: Biological Products (No Diagnostic Substances)
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- 2018
- News (4w)
- 8
- 18
- Recent ratings
- 18
- 18
Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings, Inc. develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is based in Boston, Massachusetts.
Twist Bioscience Corporation
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with ImmunoPrecise Antibodies Ltd.; Victorian Clinical Genetic Services; Vivlion GmbH; and Kyowa Kirin Pharmaceutical Research, Inc. Twist Bioscience Corporation was founded in 2013 and is headquartered in South San Francisco, California.
Latest DNA
- SEC Form 10-Q filed by Ginkgo Bioworks Holdings Inc.
- Ginkgo Bioworks Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Ginkgo Bioworks Reports Third Quarter 2026 Results; Signs First Autonomous Lab Sale to a Top-Tier Pharma Company Novo
- SEC Form 8-K filed by Ginkgo Bioworks Holdings Inc.
- Officer Coen Steven P. sold $7,770 worth of shares (766 units at $10.14) (SEC Form 4)
- Officer Shetty Reshma P. sold $417,608 worth of shares (41,172 units at $10.14) (SEC Form 4)
- Large owner Canton Barry sold $417,608 worth of shares (41,172 units at $10.14) (SEC Form 4)
- Officer Kelly Jason R sold $463,353 worth of shares (45,682 units at $10.14) (SEC Form 4)
- Ginkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program
- Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop
Latest TWST
- Twist Bioscience Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Twist Bioscience Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results
- Amendment: SEC Form SCHEDULE 13G/A filed by Twist Bioscience Corporation
- Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- SEC Form SCHEDULE 13G filed by Twist Bioscience Corporation
- Twist Bioscience to Present at Upcoming Investor Conferences
- Officer Cho Dennis sold $128,496 worth of shares (949 units at $135.40), decreasing direct ownership by 1% to 62,840 units (SEC Form 4) to satisfy withholding tax
- SVP of Human Resources Green Paula sold $136,350 worth of shares (1,007 units at $135.40), decreasing direct ownership by 0.94% to 105,625 units (SEC Form 4) to satisfy withholding obligation
- Chief Accounting Officer Werner Robert F. sold $20,039 worth of shares (148 units at $135.40), decreasing direct ownership by 0.34% to 42,769 units (SEC Form 4) to satisfy tax liability
- Chief Executive Officer Leproust Emily M. sold $619,193 worth of shares (4,573 units at $135.40), decreasing direct ownership by 0.81% to 558,187 units (SEC Form 4) (withholding obligation)